About Diabetes & Metabolic Health
Our metabolic health portfolio encompasses leading antidiabetic APIs including biguanides, sulfonylureas, DPP-4 inhibitors, and SGLT2 inhibitors manufactured to strict international quality standards.
Our metabolic health portfolio encompasses leading antidiabetic APIs including biguanides, sulfonylureas, DPP-4 inhibitors, and SGLT2 inhibitors manufactured to strict international quality standards.